There is a substantial body of scientific research that provides evidence that exposure to common household mold can lead to significant and chronic illness. Mold’s byproducts: biotoxins, mycotoxins and endotoxins have a great propensity to weaken the immune system, rendering it susceptible to other pathogens and intracellular damage leading to cancer and a myriad of different types of localized systemic infections. The four most common types of indoor mold create a host of different myco/ endo/ bio toxins that each have the propensity to interfere with and damage tissue in the kidney, liver, brain and respiratory systems. It is believed that mold exposure as such, is the root cause cause of most kidney, liver and non-smoking related lung cancers.
Dr R. Shoemaker, a pioneer in bringing mold related illnesses into the public eye is well known for his Biotoxin Pathways chart, which has been influential in outlining the delineation of testing and treatment for patients who suffer from mycotoxin exposure and related illnesses. Laboratory testing with specificity has proven to be very difficult due to the fact that many mycotoxins are intracellular. When mycotoxins are sequestered within a cell, they are often undetectable. Testing with strict protocol or using alternative testing methods is now the standard approach for those who may have been exposed to mold. Testing those who are suffering from chronic illness without any known cause for: VIP, MSH, TGF Beta-1, C4a, HLA, AGA IgA/ IgG, ACTH,/ Cortisol, VEGF, ACLA IgA/IgG/ IgM, ADH, Osmolality, MMP9 & Leptin has proven to be effective. If the collective of tests reflect non-normative levels, it can be asserted with great certainty whether one is being affected by mycotoxin exposure and whether susceptibility is higher as some indicators will show higher levels of various cellular types in which mycotoxins are stored.
Treatment, beginning with remediation of the mold source is critical. It is also important to focus on the biological implications of exposure by targeting mycotoxins on a cellular level. With mycotoxin binders individuals exposed to mold can remove mycotoxins from their system(s) by binding mycotoxins to [a binding substance] in order to carry them out of the system via biological processes. Some binders include products such as low-sugar content Cholestyramine, charcoal, bentonite clay, chlorella, apple pectin, clay and other binders such as zeolites, chitosan and modified citrus pectin. These substances have been well known as great detoxifiers and also are effective in removing heavy metals from the body’s fat stores. With the exception of pectin, chlorella charcoal and bentonite clay, binders should only be used under supervision of a practitioner who has proper training in detoxification methodology and who is familiar with all of the laboratory testing relevant to mycotoxin indication.